Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype

Biology Open

Volumn 3, Issue 5, 2014, Pages 372-378

  Federico, Antonella ^a   Forzati, Floriana ^a   Esposito, Francesco ^a   Arra, Claudio ^b   Palma, Giuseppe ^a,b   Barbieri, Antonio ^b   Palmieri, Dario ^a   Fedele, Monica ^a   Pierantoni, Giovanna Maria ^a   De Martino, Ivana ^a   Fusco, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

E2F; HMGA1; HMGA2; Pygmy

Indexed keywords

EID: 84978154068     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20146759     Document Type: Article

References (45)

1. Anand, A. and Chada, K. (2000). In vivo modulation of Hmgic reduces obesity. Nat. Genet. 24, 377-380.
2. Arlotta, P., Tai, A. K., Manfioletti, G., Clifford, C., Jay, G. and Ono, S. J. (2000). Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J. Biol. Chem. 275, 14394-14400.
3. Balcerczak, M., Pasz-Walczak, G., Balcerczak, E., Wojtylak, M., Kordek, R. and Mirowski, M. (2003). HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging. Pathol. Res. Pract. 199, 641-646.
4. Baldassarre, G., Fedele, M., Battista, S., Vecchione, A., Klein-Szanto, A. J., Santoro, M., Waldmann, T. A., Azimi, N., Croce, C. M. and Fusco, A. (2001). Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 98, 7970-7975.
5. Battista, S., de Nigris, F., Fedele, M., Chiappetta, G., Scala, S., Vallone, D., Pierantoni, G. M., Mega, T., Santoro, M., Viglietto, G. et al. (1998). Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene 17, 377-385.
6. Battista, S., Fidanza, V., Fedele, M., Klein-Szanto, A. J., Outwater, E., Brunner, H., Santoro, M., Croce, C. M. and Fusco, A. (1999). The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res. 59, 4793-4797.
7. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V. and Fusco, A. (1995). Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol. 15, 1545-1553.
8. Berlingieri, M. T., Pierantoni, G. M., Giancotti, V., Santoro, M. and Fusco, A. (2002). Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21, 2971-2980.
9. Buysse, K., Reardon, W., Mehta, L., Costa, T., Fagerstrom, C., Kingsbury, D. J., Anadiotis, G., McGillivray, B. C., Hellemans, J., de Leeuw, N. et al. (2009). The 12q14 microdeletion syndrome: additional patients and further evidence that HMGA2 is an important genetic determinant for human height. Eur. J. Med. Genet. 52, 101-107.
10. Carty, C. L., Johnson, N. A., Hutter, C. M., Reiner, A. P., Peters, U., Tang, H. and Kooperberg, C. (2012). Genome-wide association study of body height in African Americans: the Women's Health Initiative SNP Health Association Resource (SHARe). Hum. Mol. Genet. 21, 711-720.
11. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, S., Trapasso, F., Merciai, B. M., Fidanza, V., Giancotti, V., Santoro, M. et al. (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13, 2439-2446.
12. Chiappetta, G., Ferraro, A., Vuttariello, E., Monaco, M., Galdiero, F., De Simone, V., Califano, D., Pallante, P., Botti, G., Pezzullo, L. et al. (2008). HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Eur. J. Cancer 44, 1015-1021.
13. Chieffi, P., Battista, S., Barchi, M., Di Agostino, S., Pierantoni, G. M., Fedele, M., Chiariotti, L., Tramontano, D. and Fusco, A. (2002). HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene 21, 3644-3650.
14. Donato, G., Martinez Hoyos, J., Amorosi, A., Maltese, L., Lavano, A., Volpentesta, G., Signorelli, F., Pentimalli, F., Pallante, P., Ferraro, G. et al. (2004). High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncol. Rep. 11, 1209-1213.
15. Esposito, F., Tornincasa, M., Chieffi, P., De Martino, I., Pierantoni, G. M. and Fusco, A., (2010). High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. Cancer Res. 70, 5379-5388.
16. Fedele, M., Berlingieri, M. T., Scala, S., Chiariotti, L., Viglietto, G., Rippel, V., Bullerdiek, J., Santoro, M. and Fusco, A. (1998). Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17, 413-418.
17. Fedele, M., Pierantoni, G. M., Berlingieri, M. T., Battista, S., Baldassarre, G., Munshi, N., Dentice, M., Thanos, D., Santoro, M., Viglietto, G. et al. (2001). Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res. 61, 4583-4590.
18. Fedele, M., Battista, S., Kenyon, L., Baldassarre, G., Fidanza, V., Klein-Szanto, A. J., Parlow, A. F., Visone, R., Pierantoni, G. M., Outwater, E. et al. (2002). Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 21, 3190-3198.
19. Fedele, M., Pentimalli, F., Baldassarre, G., Battista, S., Klein-Szanto, A. J., Kenyon, L., Visone, R., De Martino, I., Ciarmiello, A., Arra, C. et al. (2005). Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 24, 3427-3435.
20. Fedele, M., Fidanza, V., Battista, S., Pentimalli, F., Klein-Szanto, A. J., Visone, R., De Martino, I., Curcio, A., Morisco, C., Del Vecchio, L. et al. (2006a). Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelolymphoproliferative disorders in mice. Cancer Res. 66, 2536-2543.
21. Fedele, M., Visone, R., De Martino, I., Troncone, G., Palmieri, D., Battista, S., Ciarmiello, A., Pallante, P., Arra, C., Melillo, R. M. et al. (2006b).HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9, 459-471.
22. Federico, A., Pallante, P., Bianco, M., Ferraro, A., Esposito, F., Monti, M., Cozzolino, M., Keller, S., Fedele, M., Leone, V. et al. (2009). Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res. 69, 7079-7087.
23. Flohr, A. M., Rogalla, P., Bonk, U., Puettmann, B., Buerger, H., Gohla, G., Packeisen, J., Wosniok, W., Loeschke, S. and Bullerdiek, J. (2003). High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol. Histopathol. 18, 999-1004.
24. Foti, D., Chiefari, E., Fedele, M., Iuliano, R., Brunetti, L., Paonessa, F., Manfioletti, G., Barbetti, F., Brunetti, F. M., Brunetti, A., Croce, C. M., et al. (2005). Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 11, 765-773.
25. Fusco, A. and Fedele, M. (2007). Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899-910.
26. Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Balmain, A., Portella, G., Fusco, A. and Goodwin, G. H. (1989). Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res. 184, 538-545.
27. Hendriks, A. E., Brown, M. R., Boot, A. M., Oostra, B. A., Drop, S. L. and Parks, J. S. (2011). Genetic variation in candidate genes like the HMGA2 gene in the extremely tall. Horm Res Paediatr. 76, 307-313.
28. Hodge, J. C., Cuenco, K. T., Huyck, K. L., Somasundaram, P., Panhuysen, C. I., Stewart, E. A. and Morton, C. C. (2009). Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum. Genet. 125, 257-263.
29. Johnson, K. R., Lehn, D. A. and Reeves, R. (1989). Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol. Cell. Biol. 9, 2114-2123.
30. Ligon, A. H., Moore, S. D., Parisi, M. A., Mealiffe, M. E., Harris, D. J., Ferguson, H. L., Quade, B. J. and Morton, C. C. (2005). Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am. J. Hum. Genet. 76, 340-348.
31. Makvandi-Nejad, S., Hoffman, G. E., Allen, J. J., Chu, E., Gu, E., Chandler, A. M., Loredo, A. I., Bellone, R. R., Mezey, J. G., Brooks, S. A. et al. (2012). Four loci explain 83% of size variation in the horse. PLoS ONE 7, e39929.
32. Martínez-Balbás, M. A., Bauer, U. M., Nielsen, S. J., Brehm, A. and Kouzarides, T. (2000). Regulation of E2F1 activity by acetylation. EMBO J. 19, 662-671.
33. Narita, M., Narita, M., Krizhanovsky, V., Nunez, S., Chicas, A., Hearn, S. A., Myers, M. P. and Lowe, S. W. (2006). A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126, 503-514.
34. Pierantoni, G. M., Agosti, V., Fedele, M., Bond, H., Caliendo, I., Chiappetta, G., Lo Coco, F., Pane, F., Turco, M. C., Morrone, G. et al. (2003). High-mobility group A1 proteins are overexpressed in human leukaemias. Biochem. J. 372, 145-150.
35. Reeves, R. and Nissen, M. S. (1990). The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 265, 8573-8582.
36. Scala, S., Portella, G., Fedele, M., Chiappetta, G. and Fusco, A. (2000). Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of humanmalignant neoplasias.Proc. Natl.Acad.Sci. USA97, 4256-4261.
37. Scala, S., Portella, G., Vitagliano, D., Ledent, C., Chiappetta, G., Giancotti, V., Dumont, J. and Fusco, A. (2001). HMGI-C gene expression is not required for in vivo thyroid cell transformation. Carcinogenesis 22, 251-256.
38. Seville, L. L., Shah, N., Westwell, A. D. and Chan, W. C. (2005). Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr. Cancer Drug Targets 5, 159-170.
39. Thanos, D., Du, W. and Maniatis, T. (1993). The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex. Cold Spring Harb. Symp. Quant. Biol. 58, 73-81.
40. Toledo, F. and Wahl, G. M. (2006). Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909-923.
41. Weedon, M. N., Lango, H., Lindgren, C. M., Wallace, C., Evans, D. M., Mangino, M., Freathy, R. M., Perry, J. R., Stevens, S., Hall, A. S. et al.; Diabetes Genetics Initiative; Wellcome Trust Case Control Consortium; Cambridge GEM Consortium. (2008). Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 40, 575-583.
42. Wood, L. J., Maher, J. F., Bunton, T. E. and Resar, L. M. (2000). The oncogenic properties of the HMG-I gene family. Cancer Res. 60, 4256-4261.
43. Yang, T. L., Guo, Y., Zhang, L. S., Tian, Q., Yan, H., Guo, Y. F. and Deng, H. W. (2010). HMGA2 is confirmed to be associated with human adult height. Ann. Hum. Genet. 74, 11-16.
44. Zaidi, M. R., Okada, Y. and Chada, K. K. (2006).Misexpression of full-lengthHMGA2 induces benign mesenchymal tumors in mice. Cancer Res. 66, 7453-7459.
45. Zhou, X., Benson, K. F., Ashar, H. R. and Chada, K. (1995). Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376, 771-774.